ArticleCureus2025
Aggressive Pelvic Angiomyxoma Presenting As Vulvar Swelling in a Young Female: A Radiologic and Pathologic Correlation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aggressive angiomyxoma (AA) is a rare mesenchymal tumor that primarily occurs in women of reproductive age and arises in the pelvis and perineum (perineal area). We present the case of a 20-year-old unmarried female from Afghanistan who was sent for assessment of worsening swelling in the left vulvar and perineal regions. Imaging demonstrated a large, minimal enhancement, soft tissue mass in the left hemipelvis, which displaced organs but otherwise demonstrated no invasion. The lesion extended to the ischiorectal fossa and perineum. Owing to the clinical and radiologic findings, aggressive angiomyxoma was provisionally diagnosed, which was confirmed histologically by image-guided biopsy. The patient underwent surgical resection. Given the tumor has a known local recurrence risk, and it stained positive for estrogen and progesterone receptors, long-term follow-up and adjuvant hormonal treatment were recommended. This case highlights the importance of considering aggressive angiomyxoma in the imaging workup of vulvoperineal masses in younger women and the importance of multidisciplinary management, including imaging, to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.